Mesoblast reported -41273000 in EBITDA for its fiscal semester ending in June of 2024.


Ebitda Change Date
Avita Medical AUD -9863000 3.95M Dec/2024
Clinuvel Pharmaceuticals AUD 40.01M 21.64M Jun/2024
Cochlear AUD 323M 24.1M Dec/2024
CSL USD 3.23B 1.52B Dec/2024
Pacific Edge NZD -13968000 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5859230 3.79M Dec/2024
PYC Therapeutics AUD -25596250 3.68M Dec/2024
Ramsay Health Care AUD 1.02B 22.3M Dec/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Starpharma Holdings AUD -4853000 1.73M Dec/2024
Telix Pharmaceuticals AUD 33.24M 21.45M Jun/2025